DGAP-News
SHOP APOTHEKE EUROPE promoted to MDAX.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
NOT FOR PUBLICATION OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA AND JAPAN. |
SHOP APOTHEKE EUROPE promoted to MDAX.
Venlo, the Netherlands, 21 September 2020. The shares of SHOP APOTHEKE EUROPE are now listed in the MDAX selection index following the latest index review by Deutsche Börse.
With its promotion to the MDAX, SHOP APOTHEKE EUROPE is one of the 60 largest listed companies in Germany which, in terms of market capitalisation and stock exchange turnover, directly follow the stocks included in the DAX.
Since its IPO in October 2016, SHOP APOTHEKE EUROPE has continuously increased its market capitalisation (currently around EUR 2 billion) and share turnover. In September 2018, the company was included in the SDAX. Now, just two years later, it ascends to the MDAX.
CFO Jasper Eenhorst comments on the admission to the MDAX: "We are pleased that our growth story is understood and honoured by the capital market. The admission to the MDAX is both a recognition of
our work and an incentive to do even better for us." In addition to its dynamic operational growth in Europe, the progressive development of the company from a pure online pharmacy retailer to a
customer-centric e-pharmacy platform has led to an increase in investor interest in the past years.
ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is one of the leading and fastest-growing online pharmacies in Continental Europe. With the acquisition of Europa Apotheek Venlo in
November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the areas of OTC, beauty and personal care products as well as
prescription drugs is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018.